Johnston, Eleanor
(2018)
PROGRESS TOWARDS INVESTIGATION OF THE IMPACT OF TARGETED INHIBITION OF POTENTIAL DNA-DAMAGE RESPONSE REGULATION OF TRANSLATION IN IRRADIATED NON-SMALL CELL LUNG CANCER CELL LINES.
Master's Thesis, University of Pittsburgh.
(Unpublished)
This is the latest version of this item.
Abstract
ABSTRACT:
Lung cancer has a 5-year survival rate of 17% with current standard-of-care radiation and chemotherapies (1,2,4,8,9). Immune escape contributes to poor tumor clearance driving the development of therapies that promote anti-tumor immune responses (29-33). The cytotoxic T-lymphocyte response distinguishes cancerous cells by the presentation of mutated endogenous antigens on MHC-1 molecules (26,29-33). Radiation therapy has been shown to increase MHC-1 antigen presentation (22-23,30). It has been proposed that DNA-damage response signaling inhibits translation during radiation induced cell recovery resulting in a post-repair spike in translation and MHC-1 presentation (22-23,30). We hypothesize that ATM and ATR inhibition will disrupt the negative regulation of translation post-radiation to impact the rate of MHC-1 presentation. Increasing antigen presentation before cell recovery from radiation damage may increase the magnitude of mutant antigens to stimulate anti-tumor CD8+ T-cell activation.
This investigation attempted to monitor the impact of DNA-damage response inhibition on translation and subsequent MHC-1 presentation post-radiation at two levels. First, fluctuations in the intracellular peptide pool available for MHC-1 antigen loading was measured via the activity of Transporter associated with Antigen Processing (TAP) responsible for shuttling cytosolic peptides into the ER for MHC-1 antigen loading (20-2226). Fluorescence Recovery After Photobleaching (FRAP) of TAP1-mNeonGreen was used to calculate the lateral diffusion of TAP within the ER membrane as diffusion is inversely correlated to TAP activity. Second, MHC-1 cell surface presentation was measured via flow cytometry.
Share
Citation/Export: |
|
Social Networking: |
|
Details
Item Type: |
University of Pittsburgh ETD
|
Status: |
Unpublished |
Creators/Authors: |
|
ETD Committee: |
|
Date: |
11 September 2018 |
Date Type: |
Publication |
Defense Date: |
3 August 2018 |
Approval Date: |
11 September 2018 |
Submission Date: |
7 August 2018 |
Access Restriction: |
No restriction; Release the ETD for access worldwide immediately. |
Number of Pages: |
48 |
Institution: |
University of Pittsburgh |
Schools and Programs: |
School of Medicine > Molecular Pharmacology |
Degree: |
MS - Master of Science |
Thesis Type: |
Master's Thesis |
Refereed: |
Yes |
Uncontrolled Keywords: |
DNA-damage response, NSCLC, Radiation therapy, MHC-1 presentation, Cap-dependent translation |
Date Deposited: |
11 Sep 2018 18:34 |
Last Modified: |
11 Sep 2018 18:34 |
URI: |
http://d-scholarship.pitt.edu/id/eprint/35209 |
Available Versions of this Item
Metrics
Monthly Views for the past 3 years
Plum Analytics
Actions (login required)
 |
View Item |